EYEPOINT PHARMACEUTICALS INC (EYPT) Institutional Ownership Changes & 13F Activity

EYEPOINT PHARMACEUTICALS INC (EYPT). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Commodore Capital Lp, Adage Capital Partners Gp, L.L.C., Cormorant Asset Management, Lp, Ameriprise Financial Inc, and Two Sigma Investments, Lp.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
State Street CorpBuy+260,343+12.4%2,357,545$33.71MQ2 2026Sep 22, 2026
Manufacturers Life Insurance Company, TheSell-938-2.6%35,134$502.42KQ2 2026Sep 09, 2026
Citadel Advisors LlcBuy+71,735+3.8%1,977,610$28.28MQ2 2026Sep 02, 2026
Corient Private Wealth LlcSell-303-0.2%127,199$1.82MQ2 2026Aug 27, 2026
California State Teachers Retirement SystemSell-2,461-2.3%102,640$1.47MQ2 2026Aug 24, 2026
Commodore Capital LpBuy+1,775,000+62.8%4,600,000$65.78MQ2 2026Aug 14, 2026
Adage Capital Partners Gp, L.L.C.Buy+1,527,792+46.3%4,827,792$69.04MQ2 2026Aug 14, 2026
Cormorant Asset Management, LpSell-1,265,000-15.3%7,000,000$100.10MQ2 2026Aug 14, 2026
Ameriprise Financial IncBuy+848,410—848,410$12.13MQ2 2026Aug 14, 2026
Two Sigma Investments, LpBuy+750,828+174.5%1,181,143$16.89MQ2 2026Aug 14, 2026
Stempoint Capital LpSell-472,293-58.3%338,471$4.84MQ2 2026Aug 14, 2026
Balyasny Asset Management L.P.Buy+373,621+26.0%1,812,358$25.92MQ2 2026Aug 14, 2026
Ghisallo Capital Management LlcBuy+350,000—350,000$5.00MQ2 2026Aug 14, 2026
Bank Of America CorpSell-318,395-83.0%65,048$930.19KQ2 2026Aug 14, 2026
Eversept Partners, LpBuy+297,735—297,735$4.26MQ2 2026Aug 14, 2026
Paradigm Biocapital Advisors LpSell-252,040-8.0%2,890,397$41.33MQ2 2026Aug 14, 2026
Goldman Sachs Group IncSell-234,619-33.5%465,087$6.65MQ2 2026Aug 14, 2026
Woodline Partners LpBuy+200,000+199.1%300,463$4.30MQ2 2026Aug 14, 2026
Granahan Investment Management, LlcSell-147,721-49.7%149,387$2.14MQ2 2026Aug 14, 2026
Invesco Ltd.Buy+116,204—116,204$1.66MQ2 2026Aug 14, 2026
Sio Capital Management, LlcSell-98,655-13.7%623,130$8.91MQ2 2026Aug 14, 2026
Qube Research & Technologies LtdBuy+72,625+62.4%189,102$2.70MQ2 2026Aug 14, 2026
Parkman Healthcare Partners LlcSell-66,637-4.9%1,288,163$18.42MQ2 2026Aug 14, 2026
Hrt Financial LpBuy+57,212—57,212$818.00KQ2 2026Aug 14, 2026
Point72 Asset Management, L.P.Buy+48,574—48,574$694.61KQ2 2026Aug 14, 2026
Rosalind Advisors, Inc.Sell-48,507-4.7%988,230$14.13MQ2 2026Aug 14, 2026
Susquehanna Portfolio Strategies, LlcBuy+48,426+34.7%187,801$2.69MQ2 2026Aug 14, 2026
Cinctive Capital Management LpBuy+44,721+160.5%72,582$1.04MQ2 2026Aug 14, 2026
Wells Fargo & Company/MnBuy+41,447+141.5%70,739$1.01MQ2 2026Aug 14, 2026
Magnetar Financial LlcBuy+39,737—39,737$568.24KQ2 2026Aug 14, 2026
Showing 30 of 173

Frequently asked questions about EYPT activity

  • Which institutional owners are buying EYPT?

    Institutional owners buying EYPT include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in EYPT activity?

    "Buy" means an investor increased their reported position in EYPT compared to the prior reporting period. This reflects growing exposure to EYEPOINT PHARMACEUTICALS INC (EYPT) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in EYPT increasing?

    Institutional interest in EYPT can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.